Expanding access to nonprescription drugs and improving public health aren’t likely to result from a US Food and Drug Administration proposed rule targeting those and other goals, say Sidney Wolfe and other public health advocates.
The agency has comments from Wolfe and others submitted in November to consider among the 182 submitted to the docket...